Not applicableStudy completedNCT05572450What this trial is testingDose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge StrainWho this might be right forInfluenza A H1N1 Hvivo 70
Early research (Phase 1)Study completedNCT00724997What this trial is testingRandomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy VolunteersWho this might be right forSeasonal Human Influenza AVIR Green Hills Biotechnology AG 48
Testing effectiveness (Phase 2)Study completedNCT00952419What this trial is testingDifferent Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 YearsWho this might be right forInfluenzaSwine-origin A/H1N1 Influenza Sanofi Pasteur, a Sanofi Company 474
Large-scale testing (Phase 3)Study completedNCT00970177What this trial is testingImmunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of AgeWho this might be right forPandemic Influenza Novartis Vaccines 812
Not applicableStudy completedNCT01191853What this trial is testingCellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza VaccinesWho this might be right forHealthy VolunteersInfluenza National Heart, Lung, and Blood Institute (NHLBI) 203
Early research (Phase 1)Study completedNCT02014870What this trial is testingSafety and Reactogenicity of a H1N1 Influenza Challenge Virus in Healthy VolunteersWho this might be right forInfluenza A Immune Targeting Systems Ltd 29
Large-scale testing (Phase 3)Study completedNCT00971542What this trial is testingImmunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine (Egg-Derived) in Healthy Subjects From 6 Months to 17 Years of AgeWho this might be right forPandemic Influenza Novartis Vaccines 778
Early research (Phase 1)Study completedNCT00989404What this trial is testingCrossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo Via Devices Administered Twice Daily for 5 DaysWho this might be right forInfluenza A Virus, H1N1 Subtype GlaxoSmithKline 18
Early research (Phase 1)Study completedNCT01688297What this trial is testingSafety Study of an Oral Vaccine to Prevent Seasonal InfluenzaWho this might be right forInfluenza Vaxart 61
Testing effectiveness (Phase 2)Study completedNCT02468115What this trial is testingInfluenza Challenge Study of VIS410 in Healthy VolunteersWho this might be right forInfluenza Visterra, Inc. 46
Not applicableStudy completedNCT01007201What this trial is testingImmunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Pediatric PopulationWho this might be right forInfluenza Adimmune Corporation 183
Testing effectiveness (Phase 2)Study completedNCT01646138What this trial is testingInfluenza A 2009 H1N1 Challenge Study in Healthy AdultsWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 49
Testing effectiveness (Phase 2)Ended earlyNCT01069601What this trial is testingH1N1sw Vaccine in Adult Transplant RecipientsWho this might be right forImmunocompromised HepNet Study House, German Liverfoundation 13
Testing effectiveness (Phase 2)Study completedNCT00992212What this trial is testingImmunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vaccine in Healthy Subjects 18 or More Years of Age Both Vaccinated and Not Yet Vaccinated Against Seasonal Influenza 2009/10Who this might be right forPandemic Influenza Disease Novartis Vaccines 418
Testing effectiveness (Phase 2)Study completedNCT01258023What this trial is testingSeasonal Flu Vaccine in Adult Transplant RecipientsWho this might be right forImmunocompromisedTransplanted HepNet Study House, German Liverfoundation 122
Post-approval studies (Phase 4)Study completedNCT01079273What this trial is testingClinical Study to Evaluate Antibody and Cell Mediated Immunity of A/H1N1 Influenza Vaccine in Healthy SubjectsWho this might be right forInfluenza Opera CRO, a TIGERMED Group Company 7
Early research (Phase 1)Study completedNCT04044352What this trial is testingH1N1v Virus Challenge Study in Healthy SubjectsWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 76
Large-scale testing (Phase 3)Study completedNCT00971906What this trial is testingImmunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of AgeWho this might be right forPandemic Influenza Novartis Vaccines 660
Not applicableStudy completedNCT00995527What this trial is testingCharacterization of the Innate Immune Response in Healthy NIH Employees at Baseline and After Immunization With the H1N1 VaccineWho this might be right forHealthy Volunteers National Heart, Lung, and Blood Institute (NHLBI) 26
Early research (Phase 1)Study completedNCT04106817What this trial is testingSingle Ascending Dose Challenge Study to Determine Safety and Reactogenicity of an Influenza Challenge VirusWho this might be right forInfluenza WCCT Global 35